MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma

P. de la Puente, B. Muz, A. Jin, F. Azab, M. Luderer, N. N. Salama, A. K. Azab

Research output: Contribution to journalLetterpeer-review

15 Scopus citations
Original languageEnglish (US)
Article numbere399
JournalBlood Cancer Journal
Volume6
Issue number2
DOIs
StatePublished - 2016
Externally publishedYes

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this